Adam Logal
Vermögen: 900 327 $ am 31.05.2026
Vermögen: 900 327 $ am 31.05.2026
Adam E.
Logal is currently Director at Bio-Reference Laboratories, Inc. since 2015, Director at OPKO Biologics Ltd. since 2014, Director at Non-Invasive Monitoring Systems, Inc. starting 2025, and CFO, Treasurer, Chief Accounting Officer & SVP at OPKO Health, Inc. since 2021.
Former positions include Chairman at Xenetic Biosciences, Inc. from 2017 to 2024, Finance Director, Secretary, Treasurer & CAO at eXegenics, Inc. in 2007, Independent Director at VBI Vaccines, Inc. from 2014 to 2018, Director at SciVac Therapeutics, Inc., Chief Financial & Accounting Officer at Nabi Biopharmaceuticals from 2002 to 2007, and President at GeneDx LLC from 2020 to 2021.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
OPKO HEALTH, INC. 0,08 % | 27.05.2025 | 616.662 ( 0,08 % ) | 900 327 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| OPKO HEALTH, INC. | Finanzdirektor/CFO | 31.03.2014 |
| BIO-REFERENCE LABORATORIES INC | Direktor/Vorstandsmitglied | 20.08.2015 |
| NON-INVASIVE MONITORING SYSTEMS, INC. | Direktor/Vorstandsmitglied | 03.09.2025 |
OPKO Biologics Ltd.
OPKO Biologics Ltd. BiotechnologyHealth Technology Operates as a drug development company that develops bio-better long-acting therapeutic proteins | Direktor/Vorstandsmitglied | 01.04.2014 |
| Unternehmen | Position | Ende |
|---|---|---|
| XENETIC BIOSCIENCES, INC. | Vorsitzender | 11.12.2024 |
GeneDx LLC
GeneDx LLC Medical/Nursing ServicesHealth Services Provides genomic testing services | Präsident | 01.06.2021 |
| VBI VACCINES INC. | Direktor/Vorstandsmitglied | 01.10.2018 |
eXegenics, Inc.
eXegenics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Finanzdirektor/CFO | 13.06.2007 |
Nabi Biopharmaceuticals
Nabi Biopharmaceuticals BiotechnologyHealth Technology Develops and manufactures biopharmaceutical products | Finanzdirektor/CFO | 01.01.2007 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 10 |
|---|---|
Bio-Reference Laboratories, Inc.
Bio-Reference Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Provides laboratory testing services | Commercial Services |
Non-Invasive Monitoring Systems, Inc.
Non-Invasive Monitoring Systems, Inc. Financial ConglomeratesFinance Operates as a shell company with no operations | Finance |
Nabi Biopharmaceuticals
Nabi Biopharmaceuticals BiotechnologyHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
eXegenics, Inc.
eXegenics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
OPKO Biologics Ltd.
OPKO Biologics Ltd. BiotechnologyHealth Technology Operates as a drug development company that develops bio-better long-acting therapeutic proteins | Health Technology |
OPKO Health, Inc.
OPKO Health, Inc. Medical/Nursing ServicesHealth Services Engages in biopharmaceutical and diagnostics | Health Services |
Xenetic Biosciences, Inc.
Xenetic Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops biologic drugs, novel oncology therapeutics, and vaccinations | Health Technology |
SciVac Therapeutics, Inc.
SciVac Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
VBI Vaccines, Inc.
VBI Vaccines, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Health Technology |
GeneDx LLC
GeneDx LLC Medical/Nursing ServicesHealth Services Provides genomic testing services | Health Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen